| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 02/09/2012 | CA2806956A1 Methods and pharmaceutical compositions for treating adverse or deleterious sequellae of traumatic brain injury |
| 02/09/2012 | CA2806825A1 Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound |
| 02/09/2012 | CA2806664A1 Arylsulfonamide derivatives, compositions, and methods of use |
| 02/09/2012 | CA2804967A1 Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases |
| 02/09/2012 | CA2802935A1 Combinations comprising atypical antipsychotics and taar1 agonists |
| 02/08/2012 | EP2415770A1 Lithium derivatives of pyrroloquinoline quinone and preparation method thereof |
| 02/08/2012 | EP2415767A1 Poly (ADP-ribose) Polymerase (PARP) Inhibitors |
| 02/08/2012 | EP2415756A1 Isothiourea derivatives or isourea derivatives having bace1 inhibitory activity |
| 02/08/2012 | EP2415755A1 Plasminogen activator inhibitor-1 inhibitor |
| 02/08/2012 | EP2415472A1 Solid pharmaceutical composition containing amorphous body of solifenacin |
| 02/08/2012 | EP2415466A1 Orally disintegrating coated tablet |
| 02/08/2012 | EP2414369A1 Imidazo [2, 1-b][ 1, 3, 4]thiadiazole derivatives |
| 02/08/2012 | EP2414365A1 SUBSTITUTED [1,2,4¨TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS |
| 02/08/2012 | EP2414364A1 SUBSTITUTED Ý1,2,4¨TRIAZOLOÝ1,5-a¨PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS |
| 02/08/2012 | EP2414354A1 Hydroxy-methyl isoxazole derivatives as gaba a modulators |
| 02/08/2012 | EP2414351A1 Novel salt of 1,3,5-triazine-2,4,6-triamine derivative |
| 02/08/2012 | EP2414349A1 3-ý1,4¨oxazepane-4-pyrimidone derivatives |
| 02/08/2012 | EP2414335A2 A process for the purification of eslicarbazepine acetate |
| 02/08/2012 | EP2414332A1 Acrylamide compounds and the use thereof |
| 02/08/2012 | EP2414330A2 Piperidine and piperazine derivatives as autotaxin inhibitors |
| 02/08/2012 | EP2413971A1 Plant fiber product and method for its manufacture |
| 02/08/2012 | EP2413970A2 New therapeutic approaches for treating neuroinflammatory conditions |
| 02/08/2012 | EP2413940A1 Compositions comprising 2, 4, 6-triamino-1, 3, 5-triazine derivatives for treatment of schizophrenia |
| 02/08/2012 | EP2413935A1 Low dose pipamperone in treating mood disorders |
| 02/08/2012 | EP2413933A2 Composition of 2,4,6-trifluoro-n-ý6-(1-methyl-piperidin-4-carbonyl)-pyridin-2-yl¨-benzamide |
| 02/08/2012 | EP2413929A2 Method of treating cognitive impairment |
| 02/08/2012 | EP2413926A2 Compositions of cholinesterase inhibitors |
| 02/08/2012 | EP2413701A1 Sulfonyl-azetidin-3-yl-methylamine amide analogs as glyt1 inhibitors, methods for making same, and use of same in treating psychiatric disorders |
| 02/08/2012 | EP2413696A1 Compositions for treatment of alzheimer's disease |
| 02/08/2012 | EP2321321B1 Triazolo [4, 5-d]pyramidine derivatives and their use as purine receptor antagonists |
| 02/08/2012 | EP2176251B1 5-pyridinone substituted indazoles and pharmaceutical compositions thereof |
| 02/08/2012 | EP2166852B1 Therapeutic pyrazoloquinoline derivatives |
| 02/08/2012 | EP2121653B1 Carboxamide compounds and their use as calpain inhibitors |
| 02/08/2012 | EP2075004B1 Use of epidermal growth factor for the morphofunctional restoration of peripheral nerves in diabetic neuropathy |
| 02/08/2012 | EP1989208B1 New morphine compounds for pharmaceutical compositions |
| 02/08/2012 | CN1934091B 治疗神经变性障碍的咪唑化合物 Treatment of neurodegenerative disorders imidazole compound |
| 02/08/2012 | CN102348692A Substituted 2-mercaptoquinoline-3-carboxamides as kcnq2/3 modulators |
| 02/08/2012 | CN102348457A Compositions and methods for prophylaxis and treatment of addictions |
| 02/08/2012 | CN102344491A Interferon alpha antibodies and their uses |
| 02/08/2012 | CN102344485A Peptide beta secretase inhibitor for treating alzheimer's disease, and use thereof |
| 02/08/2012 | CN102344457A Spirocyclic aminoquinolones as gsk-3 inhibitors |
| 02/08/2012 | CN102344443A Open-loop maleimide compound utilizing click chemosynthesis and application in treating diseases thereof |
| 02/08/2012 | CN102344442A Novel crystal form of tandospirone citrate and preparation method and application thereof |
| 02/08/2012 | CN102344408A Double-effect anesthetic |
| 02/08/2012 | CN102344402A Benzoazacyclo hydroxyethylamine compounds, preparation method thereof and purposes thereof |
| 02/08/2012 | CN102344398A 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors |
| 02/08/2012 | CN102343098A Functionalized magnetic nanoparticles and methods of use thereof |
| 02/08/2012 | CN102343084A Amylin and amylin agonists for treating psychiatric diseases and disorders |
| 02/08/2012 | CN102343038A Medicament for treating cerebrosis such as hemiplegic cerebral palsy, falling sickness, Parkinson, headache, insomnia and the like |
| 02/08/2012 | CN102343037A Drug with effects of bacterium resistance, disinfection, blood circulation promotion, blood stasis removal, immunity improvement, life prolonging and aging delay |
| 02/08/2012 | CN102343035A Traditional Chinese medicine formula for treating epilepsy |
| 02/08/2012 | CN102343011A Traditional Chinese medicine composition for treating neuradynamia |
| 02/08/2012 | CN102343000A Traditional Chinese medicine composition with blood cooling and diarrhea stopping functions for livestock and poultries |
| 02/08/2012 | CN102342994A Traditional Chinese medicine for treating trigeminal neuralgia |
| 02/08/2012 | CN102342992A Chinese medicinal composition for treating insomnia and preparation method of preparation thereof |
| 02/08/2012 | CN102342970A Wild chrysanthemum extract as well as preparation method and use of same |
| 02/08/2012 | CN102342966A Traditional Chinese medicine medicinal liquor formula containing ginseng, glossy ganoderma, pilos antler and five animal rib |
| 02/08/2012 | CN102342938A Methods and compositions for treatment and management of cancers |
| 02/08/2012 | CN102342927A Method for extracting silkworm chrysalis extract |
| 02/08/2012 | CN102342924A Medicine composition containing agomelatine |
| 02/08/2012 | CN102342702A Medicinal pillow |
| 02/08/2012 | CN102133198B 一种酒石酸艾芬地尔冻干粉针剂及其制备方法 One kind of tartaric acid Ifenprodil freeze-dried powder and its preparation method |
| 02/08/2012 | CN101991568B 洋川芎内酯i在制备抗抑郁症药物、偏头痛药物及其他5-羟色胺能系统相关疾病药物中的应用 Yang Chuan Xiong lactone i in the preparation of antidepressants, migraine drugs and other serotonergic system-related diseases can medicament |
| 02/08/2012 | CN101942444B 一种人鼠同源性nmda受体nr2b的小rna及其应用 A human mouse homology nmda receptor nr2b small rna Its Applications |
| 02/08/2012 | CN101850123B 核壳型荧光标记磁性药物无机纳米杂化材料及制备方法 Magnetic core-shell fluorescent labeled drug Inorganic Hybrid Materials and preparation methods |
| 02/08/2012 | CN101829127B 3-乙氧羰基苯基-β-D-乙酰化糖苷治疗抑郁症的用途 3-ethoxycarbonyl-phenyl -β-D- glucoside acetylation use in treatment of depression |
| 02/08/2012 | CN101792485B α型芋螺多肽及其应用 α-type Conus peptides and its application |
| 02/08/2012 | CN101766746B 外用蜂毒擦剂 Topical liniment venom |
| 02/08/2012 | CN101703743B 一种治疗胸脘胀痛和精神抑郁疾病的药物及其制备方法 A pharmaceutical preparation method thereof chest abdominal pain and mental illness treatment of depression |
| 02/08/2012 | CN101632730B 一种中药组合物在制备治疗情感性精神病药物中的应用 A Chinese medicinal composition for the preparation of a medicament for the treatment of affective disorders |
| 02/08/2012 | CN101569626B 使用巴比土酸衍生物治疗运动障碍的方法 Use barbituric acid derivatives for the treatment of movement disorders methods |
| 02/08/2012 | CN101541760B 二氨基环己烷和二氨基环戊烷衍生物 Diaminocyclohexane and di-amino-cyclopentane derivatives |
| 02/08/2012 | CN101502546B 人参(根)寡糖制备,及其新用途 Ginseng (root) oligosaccharide preparation, and new uses |
| 02/08/2012 | CN101374518B 新型组氨酸衍生物 The new histidine derivatives |
| 02/08/2012 | CN101310772B 用于诱导神经发生的氧化氮供体 For nitric oxide donor-induced neurogenesis |
| 02/08/2012 | CN101062906B 胍丁胺硫酸盐水合物及其用于戒毒,抗炎,降血糖以及胍丁胺代谢异常所致疾病的用途 Agmatine sulfate hydrate thereof for detoxification, anti-inflammatory, hypoglycemic and agmatine metabolism disorders caused by abnormal use |
| 02/07/2012 | US8110598 Heterocyclic compounds, their preparation, pharmaceutical compositions containing them and their use in medicine |
| 02/07/2012 | US8110587 Aryl ureas as kinase inhibitors |
| 02/07/2012 | US8110586 8-aza-bicyclo[3.2.1]octane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 02/07/2012 | US8110567 Phenyl-piperazine derivatives as serotonin reuptake inhibitors |
| 02/07/2012 | US8110566 Therapeutic agents 713 |
| 02/07/2012 | US8110549 Alpha-conotoxin peptides |
| 02/07/2012 | US8110378 Nucleic acids encoding DCRS5 |
| 02/07/2012 | US8110177 Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 02/07/2012 | CA2648569C Pyridyl amide t-type calcium channel antagonists |
| 02/07/2012 | CA2624175C Cgrp peptide antagonists and conjugates |
| 02/07/2012 | CA2516514C Arylvinylazacycloalkane compounds and methods of preparation and use thereof |
| 02/07/2012 | CA2509068C Antibody ("11c7") anti nogo a and its pharmaceutical use |
| 02/07/2012 | CA2492404C Piperidinetriol derivatives as inhibitors of glycosylceramide synthase |
| 02/07/2012 | CA2486144C Compositions comprising an angiotensin receptor blocker, a calcium channel blocker and a diuretic |
| 02/07/2012 | CA2466536C Transdermal transport of compounds |
| 02/07/2012 | CA2429563C Process for the preparation of donepezil |
| 02/02/2012 | WO2012016229A2 Oxytocin treatment to improve memory and modify blood glucose |
| 02/02/2012 | WO2012016081A2 Method and therapeutic for the treatment and regulation of memory formation |
| 02/02/2012 | WO2012015910A2 Use of adnf polypeptides for treating neurodegenerative diseases |
| 02/02/2012 | WO2012015749A1 Treatment of cognitive disorders with certain alpha-7 nicotinic acid receptor agonists in combination with acetylcholinesterase inhibitors |
| 02/02/2012 | WO2012015027A1 Therapeutic agent or prophylactic agent for neuropathic pain |
| 02/02/2012 | WO2012015024A1 Ethinyl-pyrazole derivative |
| 02/02/2012 | WO2012014994A1 Naphthalene derivative |
| 02/02/2012 | WO2012014993A1 Agent for increasing translation initiation factor or translation elongation factor, and use thereof for medical purposes |